World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Diastrophic dysplasia is a rare genetic disorder that affects bone and cartilage development. It is a type of skeletal dysplasia, a group of conditions characterized by abnormalities in the growth and development of bones and cartilage. Diastrophic dysplasia specifically falls under the category of short-limbed dwarfism.Â
The condition is inherited in an autosomal recessive manner, meaning that both parents must carry a copy of the mutated gene for a child to be affected. Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, which provides instructions for producing a protein called diastrophic dysplasia sulfate transporter (DTDST). This protein is essential for the normal development of cartilage and bone.Â
Â
Epidemiology
Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, and there can be variations in the specific mutations leading to the disorder. This genetic heterogeneity can contribute to variability in the clinical presentation and prevalence.Â
Due to its rarity and the variability in its clinical features, Diastrophic dysplasia might be underdiagnosed or misdiagnosed in some cases. The prevalence of genetic disorders can vary among different populations and ethnic groups. As diagnostic technologies and genetic testing capabilities improve, there may be an increase in the identification of individuals with Diastrophic dysplasia.Â
Â
Anatomy
Pathophysiology
Proteoglycans are large molecules found in the extracellular matrix of connective tissues, including cartilage. Sulfation is a process that involves the addition of sulfate groups to certain molecules, including proteoglycans.Â
Proper sulfation of proteoglycans is essential for the normal development and maintenance of cartilage. Mutations in the SLC26A2 gene result in the production of a nonfunctional or impaired DTDST protein. The defective DTDST protein disrupts the sulfate transport process, leading to reduced sulfation of proteoglycans.Â
Â
Etiology
The sulfate transport process is crucial for the sulfation of proteoglycans, which are large molecules found in the extracellular matrix of connective tissues, including cartilage.Â
Sulfation of proteoglycans is necessary for the normal development and maintenance of cartilage. Insufficient sulfation of proteoglycans due to the mutated DTDST protein disrupts the normal development of cartilage and bones.Â
This disruption leads to the characteristic features of Diastrophic dysplasia, including short limbs, joint deformities, and other skeletal abnormalities.Â
Â
Genetics
Prognostic Factors
The extent and severity of skeletal abnormalities, including limb shortening and joint deformities. Severe skeletal deformities may pose greater challenges for mobility and daily activities.Â
The presence and severity of joint problems, such as hip dysplasia or clubfoot, can influence the prognosis. Joint issues may require surgical interventions and ongoing orthopedic care.Â
Cardiovascular complications are not a primary feature of Diastrophic dysplasia, but individuals with the condition may still need monitoring for any associated heart issues.Â
Clinical History
Age Group:Â Â
The age group affected by Diastrophic dysplasia includes infants, children, and adults. As it is a genetic disorder, individuals with Diastrophic dysplasia have the condition throughout their lives. The severity of the symptoms can vary, and individuals may face different challenges at different stages of life.Â
Â
Physical Examination
Age group
Associated comorbidity
Diastrophic dysplasia can be associated with ear abnormalities, including a high incidence of conductive hearing loss. In addition to the characteristic limb shortening and joint deformities, individuals with Diastrophic dysplasia may experience other orthopaedic issues and other joint abnormalities.Â
While cardiovascular issues are not a primary feature of Diastrophic dysplasia, some individuals may have associated heart abnormalities. Joint deformities and abnormalities may lead to joint pain and an increased risk of osteoarthritis. Management strategies may include pain relief and orthopaedic interventions.Â
Â
Associated activity
Acuity of presentation
Infants with Diastrophic dysplasia often exhibit distinctive physical features, including short limbs, joint deformities, and facial abnormalities. X-rays and other imaging studies can reveal skeletal abnormalities, aiding in the diagnosis of Diastrophic dysplasia.
These findings contribute to the prompt identification of the condition. Genetic testing, such as DNA analysis to identify mutations in the SLC26A2 gene, can provide a definitive diagnosis. This may be done when there is a suspicion of Diastrophic dysplasia based on clinical presentation.Â
Â
Differential Diagnoses
Â
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-diastrophic-dysplasia
Role of various specialists in the recovery process
Diastrophic Dysplasia has no known treatment. The goal of treatment is to minimize the development of symptoms and to promote overall health and well-being.Â
The following specialists may be necessary for an individual with the disorder:Â
An audiologist treats patients with hearing issues.Â
When you have issues with your mouth or eating, nutritionists can assist you with food intake.Â
Orthodontists treat problems pertaining to the jaw and teeth.Â
Orthopaedic physician, with a focus on issues with the bones and joints.Â
A specialist who works with children called paediatrician.Â
Occupational and physical therapists to assist individuals in learning to move and function as best they can.Â
use-of-intervention-with-a-procedure-in-treating-diastrophic-dysplasia
Â
use-of-phases-in-managing-diastrophic-dysplasia
Orthopedic interventions to manage joint deformities and maintain joint function.Â
Support groups and resources for families to connect and share experiences.Â
Medication
Future Trends
Diastrophic dysplasia is a rare genetic disorder that affects bone and cartilage development. It is a type of skeletal dysplasia, a group of conditions characterized by abnormalities in the growth and development of bones and cartilage. Diastrophic dysplasia specifically falls under the category of short-limbed dwarfism.Â
The condition is inherited in an autosomal recessive manner, meaning that both parents must carry a copy of the mutated gene for a child to be affected. Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, which provides instructions for producing a protein called diastrophic dysplasia sulfate transporter (DTDST). This protein is essential for the normal development of cartilage and bone.Â
Â
Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, and there can be variations in the specific mutations leading to the disorder. This genetic heterogeneity can contribute to variability in the clinical presentation and prevalence.Â
Due to its rarity and the variability in its clinical features, Diastrophic dysplasia might be underdiagnosed or misdiagnosed in some cases. The prevalence of genetic disorders can vary among different populations and ethnic groups. As diagnostic technologies and genetic testing capabilities improve, there may be an increase in the identification of individuals with Diastrophic dysplasia.Â
Â
Proteoglycans are large molecules found in the extracellular matrix of connective tissues, including cartilage. Sulfation is a process that involves the addition of sulfate groups to certain molecules, including proteoglycans.Â
Proper sulfation of proteoglycans is essential for the normal development and maintenance of cartilage. Mutations in the SLC26A2 gene result in the production of a nonfunctional or impaired DTDST protein. The defective DTDST protein disrupts the sulfate transport process, leading to reduced sulfation of proteoglycans.Â
Â
The sulfate transport process is crucial for the sulfation of proteoglycans, which are large molecules found in the extracellular matrix of connective tissues, including cartilage.Â
Sulfation of proteoglycans is necessary for the normal development and maintenance of cartilage. Insufficient sulfation of proteoglycans due to the mutated DTDST protein disrupts the normal development of cartilage and bones.Â
This disruption leads to the characteristic features of Diastrophic dysplasia, including short limbs, joint deformities, and other skeletal abnormalities.Â
Â
The extent and severity of skeletal abnormalities, including limb shortening and joint deformities. Severe skeletal deformities may pose greater challenges for mobility and daily activities.Â
The presence and severity of joint problems, such as hip dysplasia or clubfoot, can influence the prognosis. Joint issues may require surgical interventions and ongoing orthopedic care.Â
Cardiovascular complications are not a primary feature of Diastrophic dysplasia, but individuals with the condition may still need monitoring for any associated heart issues.Â
Age Group:Â Â
The age group affected by Diastrophic dysplasia includes infants, children, and adults. As it is a genetic disorder, individuals with Diastrophic dysplasia have the condition throughout their lives. The severity of the symptoms can vary, and individuals may face different challenges at different stages of life.Â
Â
Diastrophic dysplasia can be associated with ear abnormalities, including a high incidence of conductive hearing loss. In addition to the characteristic limb shortening and joint deformities, individuals with Diastrophic dysplasia may experience other orthopaedic issues and other joint abnormalities.Â
While cardiovascular issues are not a primary feature of Diastrophic dysplasia, some individuals may have associated heart abnormalities. Joint deformities and abnormalities may lead to joint pain and an increased risk of osteoarthritis. Management strategies may include pain relief and orthopaedic interventions.Â
Â
Infants with Diastrophic dysplasia often exhibit distinctive physical features, including short limbs, joint deformities, and facial abnormalities. X-rays and other imaging studies can reveal skeletal abnormalities, aiding in the diagnosis of Diastrophic dysplasia.
These findings contribute to the prompt identification of the condition. Genetic testing, such as DNA analysis to identify mutations in the SLC26A2 gene, can provide a definitive diagnosis. This may be done when there is a suspicion of Diastrophic dysplasia based on clinical presentation.Â
Â
Â
Â
Diastrophic Dysplasia has no known treatment. The goal of treatment is to minimize the development of symptoms and to promote overall health and well-being.Â
The following specialists may be necessary for an individual with the disorder:Â
An audiologist treats patients with hearing issues.Â
When you have issues with your mouth or eating, nutritionists can assist you with food intake.Â
Orthodontists treat problems pertaining to the jaw and teeth.Â
Orthopaedic physician, with a focus on issues with the bones and joints.Â
A specialist who works with children called paediatrician.Â
Occupational and physical therapists to assist individuals in learning to move and function as best they can.Â
Â
Orthopedic interventions to manage joint deformities and maintain joint function.Â
Support groups and resources for families to connect and share experiences.Â
Diastrophic dysplasia is a rare genetic disorder that affects bone and cartilage development. It is a type of skeletal dysplasia, a group of conditions characterized by abnormalities in the growth and development of bones and cartilage. Diastrophic dysplasia specifically falls under the category of short-limbed dwarfism.Â
The condition is inherited in an autosomal recessive manner, meaning that both parents must carry a copy of the mutated gene for a child to be affected. Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, which provides instructions for producing a protein called diastrophic dysplasia sulfate transporter (DTDST). This protein is essential for the normal development of cartilage and bone.Â
Â
Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, and there can be variations in the specific mutations leading to the disorder. This genetic heterogeneity can contribute to variability in the clinical presentation and prevalence.Â
Due to its rarity and the variability in its clinical features, Diastrophic dysplasia might be underdiagnosed or misdiagnosed in some cases. The prevalence of genetic disorders can vary among different populations and ethnic groups. As diagnostic technologies and genetic testing capabilities improve, there may be an increase in the identification of individuals with Diastrophic dysplasia.Â
Â
Proteoglycans are large molecules found in the extracellular matrix of connective tissues, including cartilage. Sulfation is a process that involves the addition of sulfate groups to certain molecules, including proteoglycans.Â
Proper sulfation of proteoglycans is essential for the normal development and maintenance of cartilage. Mutations in the SLC26A2 gene result in the production of a nonfunctional or impaired DTDST protein. The defective DTDST protein disrupts the sulfate transport process, leading to reduced sulfation of proteoglycans.Â
Â
The sulfate transport process is crucial for the sulfation of proteoglycans, which are large molecules found in the extracellular matrix of connective tissues, including cartilage.Â
Sulfation of proteoglycans is necessary for the normal development and maintenance of cartilage. Insufficient sulfation of proteoglycans due to the mutated DTDST protein disrupts the normal development of cartilage and bones.Â
This disruption leads to the characteristic features of Diastrophic dysplasia, including short limbs, joint deformities, and other skeletal abnormalities.Â
Â
The extent and severity of skeletal abnormalities, including limb shortening and joint deformities. Severe skeletal deformities may pose greater challenges for mobility and daily activities.Â
The presence and severity of joint problems, such as hip dysplasia or clubfoot, can influence the prognosis. Joint issues may require surgical interventions and ongoing orthopedic care.Â
Cardiovascular complications are not a primary feature of Diastrophic dysplasia, but individuals with the condition may still need monitoring for any associated heart issues.Â
Age Group:Â Â
The age group affected by Diastrophic dysplasia includes infants, children, and adults. As it is a genetic disorder, individuals with Diastrophic dysplasia have the condition throughout their lives. The severity of the symptoms can vary, and individuals may face different challenges at different stages of life.Â
Â
Diastrophic dysplasia can be associated with ear abnormalities, including a high incidence of conductive hearing loss. In addition to the characteristic limb shortening and joint deformities, individuals with Diastrophic dysplasia may experience other orthopaedic issues and other joint abnormalities.Â
While cardiovascular issues are not a primary feature of Diastrophic dysplasia, some individuals may have associated heart abnormalities. Joint deformities and abnormalities may lead to joint pain and an increased risk of osteoarthritis. Management strategies may include pain relief and orthopaedic interventions.Â
Â
Infants with Diastrophic dysplasia often exhibit distinctive physical features, including short limbs, joint deformities, and facial abnormalities. X-rays and other imaging studies can reveal skeletal abnormalities, aiding in the diagnosis of Diastrophic dysplasia.
These findings contribute to the prompt identification of the condition. Genetic testing, such as DNA analysis to identify mutations in the SLC26A2 gene, can provide a definitive diagnosis. This may be done when there is a suspicion of Diastrophic dysplasia based on clinical presentation.Â
Â
Â
Â
Diastrophic Dysplasia has no known treatment. The goal of treatment is to minimize the development of symptoms and to promote overall health and well-being.Â
The following specialists may be necessary for an individual with the disorder:Â
An audiologist treats patients with hearing issues.Â
When you have issues with your mouth or eating, nutritionists can assist you with food intake.Â
Orthodontists treat problems pertaining to the jaw and teeth.Â
Orthopaedic physician, with a focus on issues with the bones and joints.Â
A specialist who works with children called paediatrician.Â
Occupational and physical therapists to assist individuals in learning to move and function as best they can.Â
Â
Orthopedic interventions to manage joint deformities and maintain joint function.Â
Support groups and resources for families to connect and share experiences.Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
